A61K 38/07
Tetrapeptides
A61K38/07 (Tetrapeptides) appears on 942 US grants and 1,824 published applications in this corpus.
Search patents in A61K- Granted patents
- 942
- Published applications
- 1,824
- Assignees
- 787
- Inventors
- 2,969
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 8 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 6 | 1 |
| 2002 | 9 | 8 |
| 2003 | 9 | 28 |
| 2004 | 7 | 27 |
| 2005 | 12 | 24 |
| 2006 | 16 | 31 |
| 2007 | 10 | 42 |
| 2008 | 15 | 40 |
| 2009 | 15 | 35 |
| 2010 | 18 | 51 |
| 2011 | 21 | 46 |
| 2012 | 28 | 50 |
| 2013 | 38 | 85 |
| 2014 | 49 | 115 |
| 2015 | 69 | 142 |
| 2016 | 72 | 100 |
| 2017 | 54 | 119 |
| 2018 | 59 | 117 |
| 2019 | 66 | 126 |
| 2020 | 63 | 117 |
| 2021 | 45 | 119 |
| 2022 | 55 | 88 |
| 2023 | 47 | 101 |
| 2024 | 57 | 99 |
| 2025 | 38 | 71 |
| 2026 | 33 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CD38 antibody drug conjugate15 Sep 2026US 12,734,209 B2Ogory, Inc.
- Compounds comprising a linker for increasing transcyclooctene stability25 Aug 2026US 12,714,752 B2Tagworks Pharmaceuticals B.V.
- Compositions and methods for treating granulomatosis with polyangiitis11 Aug 2026US 12,702,701 B2Canem Holdings, LLC
- Thermogenic compositions and methods4 Aug 2026US 12,697,366 B2Ohio State Innovation Foundation
- Screening of fixed-point coupling sites of cysteine-modified antibody-toxin conjugate (TDC)14 Jul 2026US 12,678,474 B2
- Water-soluble biomolecular glass microneedle and preparation method thereof1 Oct 2026US 2026/0294794 A1Institute of Process Engineering, Chinese Academy of Sciences
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
- Peptide pharmaceuticals for insulin resistance17 Sep 2026US 2026/0273069 A1Mederis Diabetes LLC
- Macrocyclic broad spectrum antibiotics17 Sep 2026US 2026/0274892 A1Genentech, Inc.
- Polypeptide pharmaceuticals27 Aug 2026US 2026/0248925 A1Mederis Diabetes LLC
Most cited
By later US patents
- Tetrapeptide198US 4,792,525 ALa Jolla Cancer Research Foundation · 1988
- Elastin derived composition and method of using same92US 6,069,129 AMrs, LLC · 2000
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012
- Synthetic peptide amides69US 7,402,564 B1Cara Therapeutics, Inc. · 2008
- Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides67US 6,569,834 B12003